Beyond Air (XAIR) Company Webcast

Jan 13, 2025

This company webcast features Beyond Air (Nasdaq: XAIR). Beyond Air is a commercial stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors.

This company webcast was recorded during the Lytham Partners 2025 Investor Healthcare Summit.

Skip to content